Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients
FORECAST
1 other identifier
observational
50
1 country
1
Brief Summary
This pilot study will study the impact of critical illness and ICU processes of care on the trajectory and development of frailty. It is hypothesize that frailty in survivors of critical illness will be measurable at hospital discharge, will correlate with processes of care while in ICU and will better discriminate long term outcomes when compared to severity of illness or the degree of frailty present on ICU admission. This pilot study will be conducted in a tertiary medical surgical ICU at Kingston General Hospital- Kingston, Ontario. It will inform the feasibility, timelines and sample size for the multi-center study and will allow for the refinement of study procedures and data collection methods. This study will be published separately as a stand-alone pilot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Posted
Study publicly available on registry
October 27, 2020
CompletedOctober 27, 2020
October 1, 2020
2.4 years
October 30, 2018
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of patients with a measure of frailty prior to hospital discharge.
Measure of the Frailty Index and Clinical Frailty Scale prior to discharge
6 months
Correlation of frailty severity at hospital discharge with long term outcomes (mortality, Quality of Life and Need for Institutionalization)
Clinical outcomes at 6 months will include mortality, Quality of Life (EQ5L) and need for Institutionalization
6 months
Impact of admission critical illness on the development and severity of frailty as measured by a Frailty Index or Clinical Frailty Scale
Correlation with the progression or presence of frailty as measured with the Frailty Index or Clinical Frailty Scale
28 days and at 6 months
Correlation of ICU processes of care (nutritional adequacy, mobilization and sedation) with frailty progression as measured by the Clinical Frailty Scale or Frailty Index
Correlation of processes of care in ICU (nutritional adequacy, mobilization and sedation) with frailty progression
28 days
Study Arms (1)
Critically Ill patients
No Intervention
Eligibility Criteria
Individuals who are admitted to an intensive care unit requiring therapeutic life support.
You may qualify if:
- Age \> 55 years
- Admission to ICU for over 24 hours
- Receipt of at least one therapeutic life support intervention that can only be delivered in the ICU such as mechanical ventilation (both invasive and non-invasive), vasoactive medications (vasopressors or inotropes) or acute renal replacement therapy.
You may not qualify if:
- Expected to survive for less than 72 hours after ICU admission.
- Inability to obtain baseline blood work less than 48 hours after ICU admission (i.e. study enrollment must occur within 48 hours of ICU admission allowing for the blood work to be done in the time allowed).
- No family or caregivers available to collect collateral history.
- Not able to speak English with lack of available medical translators.
- Admission to ICU with acute structural neurological disease:
- Massive stroke requiring ICU care
- Spinal cord injury with neurological deficit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. John Muscederelead
- Canadian Frailty Networkcollaborator
Study Sites (1)
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
Biospecimen
Cytokine levels and measures of immunocompetence
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Critical Care Research Director
Study Record Dates
First Submitted
October 30, 2018
First Posted
October 27, 2020
Study Start
August 1, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
October 27, 2020
Record last verified: 2020-10